Pharmacelera’s CEO, Enric Gibert has been selected as member of the Industrial Advisory Committee (IAC) of PRACE. This membership is aligned with Pharmacelera’s strategy of becoming a leader in high performance computing for drug design and influencing the European HPC agenda.

Pharmacelera’s expertise in parallelization and hardware acceleration is used in Pharmacelera’s products (PharmScreen and PharmQSAR), enabling concurrent high performance execution of drug design tasks.

PRACE is established as an international not-for-profit association (aisbl) with seat in Brussels. It has 25 member countries whose representative organizations create a pan-European supercomputing infrastructure, providing access to computing and data management resources and services for large-scale scientific and engineering applications at the highest performance level.